In an attempt to asses how the Department gave effect to government's priority of enhancing the health of the South African people, the committee visited the Centre for the AIDS Program of Research in South Africa (CAPRISA). The Committee engaged with the scientists and researchers in an attempt to broaden their understanding about the impact of the clinical trials conducted at the Vulindlela and eThekwini Research Clinics respectively. The positive outcome of the CAPRISA 004 tenofovir gel trials, offers women hope in their battle against HIV and AIDS. The Committee's concerns regarding the availability of funding for confirmation studies were raised with the Department. Furthermore, the Committee requested the Department to investigate an alleged delay by the Medicines Control Council to approve future clinical trials and registration of the tenofovir gel.